7月31日，Illumina盘中上涨5.27%，报205.095美元/股，成交额3.96亿美元。公司于7月30日盘后发布第二财季（截至6月）业绩报告。
从近期基本面来看，公司此前已连续两个季度超预期：第一财季调整后每股收益1.15美元，超市场预期9.5%，营收10.90亿美元同比增长4.8%；全年营收指引为45.2亿至46.2亿美元，高于市场预期。此外，摩根大通6月将公司评级上调至"增持"，目标价上调至185美元；公司年内推出StrataMap空间解决方案、TruPath Genome全基因组工作流等多款新品，并获批15亿美元回购授权，业务动能持续增强。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.